A round-up of share tips from the financial press

By MoneyWeek

published 22 July 2016

in Features

The stocks and sharesthe British press is tipping and recommending you avoid this week.

Three to buy

Gulf Keystone

The Sunday Times

Subscribe to MoneyWeek

Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE

Get 6 issues free

https://cdn.mos.cms.futurecdn.net/flexiimages/mw70aro6gl1676370748.jpg

Sign up to Money Morning

Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter

Kurdistan-based oil producer Gulf Keystone was a one-time market darling, but production targets were missed, shareholders jousted with the board and the company turned to the debt markets, borrowing $250m at a punitive 13%. Now the debt has been converted to equity, crushing the share price, but improving the balance sheet. Gulf Keystone can finally become the takeover target it was often rumoured to be. 3p

B&M European

The Daily TelegraphDiscount high-street retailer B&M is outgrowing M&S, Next and Poundland, which was snapped up last week by a South African conglomerate. B&M offers bargain-hunters "frying pans crammed next to flower pots underneath soap". It has 500 shops, compared with 603 for Poundland, but revenue is rising quickly. B&M is a "proven force in recessionary times", according to analysts at Peel Hunt. 256p

Topps Tiles

Investors ChronicleSince the referendum, there are bargains to be had in the retail sector. High-street tiling chain Topps Tiles is one of them. Down by a third since Brexit, its shares are braced for a major slowdown at ten times earnings. But sales are up in the last three months and customers tend to be tied into lengthy DIY projects. Seventy-five percent of its costs are in sterling and trade buyers are increasingly turning to the firm. 100p

Three to sell

Marks & Spencer

The Mail on SundayOnce the nation's favourite retailer, M&S consistently fails to provide customers with what they actually want. Chief Executive Marc Bolland fell on his sword in January and the new boss, Steve Rowe, is yet to deliver a miracle. The shares have plummeted from their level of 540p a year ago and Brexit has done M&S no favours. It looks deeply "troubled". 325p

Melrose

SharesMelrose specialises in buying engineering groups and turning them around, but its latest deal looks risky. It has paid £1.7bn for Nortek, an American ventilation business. Nortek went bust in 2009 and its share price has halved in the last year as investors fret about US growth. Yet the price Melrose offered for the firm values it at an all-time high, leaving little room for error. 640p

Evraz

Investors ChronicleWith net debt of $5.4bn, steel group Evraz has one of the largest debt piles in the sector. The international capital markets are opening up to Russian companies once again, but Evraz's borrowing looks set to jump to 3.8 times profit, threatening its flimsy dividend. Nor has the bumpy iron-ore price helped business. JP Morgan values the shares at just 98p. 155p

And the rest

Swipe to scroll horizontally

Buys	Row 0 - Cell 1
Asos	The fashion retailer continues to surprise with rapid sales growth (Shares) £44.46
AstraZeneca	Astra has had a tough year, but its pipeline is strong (Investors Chronicle) £44.72
BAE Systems	The renewal of Trident guarantees future cash flows for BAE (Telegraph) £5.34
Berkeley	The housebuilder's chairman, Tony Pidgley, is upbeat, despite Brexit (Mail) £26.24
British Land	After a brief panic, the commercial property market is stabilising (Times) £6.28
Caretech	The social-care provider will avoid any fallout from Brexit (Shares) £2.38
Capital Drilling	The mining contractor will benefit as gold and silver prices rise (Shares) 38p
Experian	The data firm is growing in health, fraud and analytics (Telegraph) £14.59
Lloyds	Lloyds' share price has been hit by Brexit, but the dividend looks bullish (Mail) 56p
NCC	Data thefts are driving customers to the cybersecurity firm (Investors Chr.) £2.99
Persimmon	The UK is chronically short of houses and Persimmon has a 7% yield (Mail) £15.71
Royal Dutch Shell	The oil giant has slashed costs and the 6%-plus dividend is safe (Barron's) £21.20
Shire	The disease specialist can trim costs after its latest merger (Telegraph) £49.75

Directors' dealings

Duncan Tatton-Brown, the finance director at online supermarket Ocado, has dived into the stock. Ocado's sales have rocketed from nothing ten years ago to £1.1bn, as it has pinched customers from supermarkets. It also has a software deal with Morrisons. But Ocado has never turned a profit and Morrisons recently signed a competing agreement with web giant Amazon, stoking fears that Amazon boss Jeff Bezos will chew up the grocery market. Tatton-Brown is betting Ocado will thrive, paying £225,000 for 100,000 shares.

A German view

Markets have been volatile in recent months, so investors should ensure they hold shares in solid companies with promising prospects, says Marion Schlegel in Der Aktionr. Swiss pharma giant Novartis fits the bill nicely. The ageing global population is a strong tailwind. The number of people over the age of 60 is set to rise by half a billion worldwide over the next 14 years, and globally, spending on health is expected to double to $15trn by 2025. Heart drug Serelaxin and breast cancer treatment LEE011 are standouts amid a strong pipeline, while Novartis looks especially well placed to prosper in the fast-growing market for "biosimilars". Indeed, its version of Pfizer's anti-inflammatory Enbrel is just as effective as the original. The stock yields 3.4%.